Alessandra Cesano
CIK 1827015 · Chief Medical Officer · last filed 2026-01-12
Alessandra Cesano is a Chief Medical Officer who has filed 17 SEC Form 4 insider transactions across 4 companies since 2021. The most recent filing, for ZYME, was dated Jan 12, 2026. Across all open-market trades the lifetime net is −$132.2K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $306.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$306.8K
4
17
-$132.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZYME | Director | — | $22.88 | — | $0 | 3 | 2026-01-12 |
| SMMT | Director | — | $14.01 | — | $0 | 5 | 2026-01-06 |
| PBYI | Director | 41,850 | $7.33 | $306.8K | -$132.2K | 6 | 2025-07-22 |
| ESSA Pharma Inc. (EPIX) Delisted | Chief Medical Officer | — | $0.20 | — | $0 | 3 | 2024-03-28 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-12 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2026-01-06 | SMMT | Grant (A) | — | $0 | EDGAR |
| 2025-07-22 | PBYI | Sell (S) | −27,000 | -$90.9K | EDGAR |
| 2025-06-17 | PBYI | Sell (S) | −12,150 | -$41.3K | EDGAR |
| 2025-06-13 | PBYI | Grant (A) | +27,000 | $0 | EDGAR |
| 2025-01-06 | SMMT | Grant (A) | — | $0 | EDGAR |
| 2024-12-12 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2024-06-21 | PBYI | Grant (A) | +27,000 | $0 | EDGAR |
| 2024-03-28 | ESSA Pharma Inc. (EPIX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-09 | ZYME | Grant (A) | — | $0 | EDGAR |